During successful pregnancy, a woman is immunologically tolerant of her genetically and antigenically disparate fetus, a state known as maternal-fetal tolerance. How this state is maintained has puzzled investigators for more than half a century. Diverse, immune and nonimmune mechanisms have been proposed; however, these mechanisms appear to be unrelated and to act independently. A population of immune suppressive cells called myeloid-derived suppressor cells (MDSCs) accumulates in pregnant mice and women. Given the profound immune suppressive function of MDSCs, it has been suggested that this cell population may facilitate successful pregnancy by contributing to maternal-fetal tolerance. We now report that myeloid cells with the characteristics of MDSCs not only accumulate in the circulation and uterus of female mice following mating but also suppress T cell activation and function in pregnant mice. Depletion of cells with the phenotype and function of MDSCs from gestation d 0.5 through d 7.5 resulted in implantation failure, increased T cell activation, and increased T cell infiltration into the uterus, whereas induction of MDSCs restored successful pregnancy and reduced T cell activation. MDSC-mediated suppression during pregnancy was accompanied by the down-regulation of L-selectin on naïve T cells and a reduced ability of naïve T cells to enter lymph nodes and become activated. Because MDSCs regulate many of the immune and nonimmune mechanisms previously attributed to maternal-fetal tolerance, MDSCs may be a unifying mechanism promoting maternal-fetal tolerance, and their induction may facilitate successful pregnancy in women who spontaneously abort or miscarry because of dysfunctional maternal-fetal tolerance.
Introduction
Successful pregnancy requires that the mother not mount an immune response against her genetically and antigenically disparate fetus. This immunologic tolerance is known as "maternal-fetal tolerance" and was first postulated by Sir Peter Medawar [1] in his 1960 Nobel lecture. Maternal-fetal tolerance has been attributed to multiple mechanisms that impair cytotoxic T cell activation and function [2] . For example, T regs inhibit type 1 immunity and expand in the blood and decidua during successful human pregnancy [3] [4] [5] . T regs are markedly decreased in women experiencing spontaneous abortions and miscarriages of genetically healthy fetuses [6] , and their absence decreases maternal-fetal tolerance in mice [7] [8] [9] . Maternal-fetal tolerance in mice has also been attributed to immune-suppressive DCs that fail to activate T cells to fetal alloantigens [10] and to myeloid cell production of the immune suppressive molecule indoleamine 2,3-dioxygenase [11] . Skewing of maternal immunity in mice and humans [12] away from a type 1 CD8 + cytotoxic T cell response and toward a type 2 response has also been associated with successful pregnancy, whereas type 1 immunity has been associated with unexplained, recurrent miscarriage [13] . This latter concept, however, is controversial because Th1 cells secreting moderate amounts of the type 1 cytokine IFN-g are present at higher frequency in the decidua vs. the blood of pregnant women [14] .
We and others have shown that many of the phenomena and functions associated with maternal-fetal tolerance are also mediated by a population of immune suppressive cells called MDSCs. MDSCs are a heterogeneous mixture of immature myeloid cells. In both humans and mice, MDSCs are phenotypically identified by surface markers that are shared with other myeloid cells; however, their defining characteristic is their immune-suppressive function [15] . Hence, the terminology "myeloid-derived suppressor cells" was adapted to identify this diverse population as cells of myeloid origin that inhibit T cell functions [16] . MDSCs were first shown to accumulate in tumorbearing patients [17] , but they also expand in mice with inflammatory conditions [18, 19] and during infection [15] and sepsis [20] . MDSCs may prevent graft rejection after transplantation of allogeneic tissues [21] and down-regulate autoimmunity [22] . They prevent T cell activation by their production of arginase [23] and reactive oxygen species [24] and their sequestration of cysteine [25] . They also downregulate naïve T cell expression of L-selectin and thereby prevent potentially reactive T cells from entering lymph nodes and becoming activated [26] . They polarize immunity toward a type 2 phenotype through their crosstalk with macrophages and their production of IL-10 [27] , and they induce the activation and accumulation of T regs [28] . MDSCs also promote neovascularization via their production of VEGF, Bv8, MMP-9, and MCP-1 [29] [30] [31] . Therefore, MDSCs are key cells that induce peripheral tolerance and promote new blood vessel formation. Because many of these functions are also critical for successful pregnancy, MDSCs may be an integral component of a healthy pregnancy.
Multiple studies have demonstrated a correlation between MDSC accumulation, function, and activation and successful pregnancy. For example, MDSCs expand in both the blood and the placenta of pregnant women [12, 32] and mice [33] , and women with reduced levels of suppressive monocytes in their blood and endometrium have higher incidences of early miscarriage [34] . Arginase, a major effector molecule of MDSC, is elevated in the placenta of pregnant women and mediates T cell hyporesponsiveness [35] . Human first-trimester, decidual stromal cells and tissue produce high levels of CCL2 [36] , which is a chemoattractant for CCR2 + MDSCs [37] . G-CSF is a potent inducer of MDSC [29, 38] , and treatment of women who have a history of recurrent miscarriages of unexplained etiology with G-CSF facilitates successful pregnancy [39, 40] . MDSC function in mice is regulated by activation of the transcription factor STAT3 [24] . The failure to activate STAT3 in the endometrium of NOD mice and mice with naturally low levels of activated STAT3 in their uterus have implantation failures [41, 42] .
Although these studies show a strong correlation between MDSC induction and function and successful pregnancy, they do not distinguish whether MDSCs are a cause or merely accompany pregnancy. To determine whether MDSCs have a definitive role in murine pregnancy, we used successful pregnancy in mice as an assay for experiments in which the levels of MDSC were manipulated. Our studies indicated that MDSCs 1) are essential for successful pregnancy because their deletion prevents pregnancy and their subsequent induction restores pregnancy, 2) mediate their effect starting immediately after mating and continuing through the period of implantation, and 3) impair T cell activation by down-regulating L-selectin on naïve T cells. -restricted, TCR specific for ova peptide 257-264 ) mice were obtained from The Jackson Laboratory (Bar Harbor, ME, USA), and bred in the UMBC animal facility. Mice in experiments were 6-16 wk old. For mating experiments, female mice were caged overnight or in the morning with male mice, and the following morning or afternoon, respectively, females were monitored for vaginal mucous plugs. Observation of a vaginal plug was considered gestation d 0.5 (E0.5). All animal procedures were approved by the UMBC Institutional Animal Care and Use Committee.
MATERIALS AND METHODS

Reagents
MDSCs and T cell depletions
Mice were depleted for MDSC using anti-Gr1 mAb (RB6-8C5) or controldepleted with an irrelevant mAb (LTF-2 
MDSC purification
MDSCs were positively purified from spleens of pregnant mice by magnetic bead sorting using LS columns and rat anti-mouse Gr1 Ab (RB6-8C5; BioLegend) with anti-rat IgG microbeads (Miltenyi Biotec, Auburn, CA, USA), as previously described [43] . Purified pregnancy-induced MDSCs were .82.5% CD11b were also collected and used as negative controls. Blood MDSCs were collected, as previously described [27] .
T cell proliferation and ELISA [43] . Culture supernatants were also collected at 48-72 h and assayed by ELISA for IL-2 and IFN-g according to the manufacturer's protocol (R&D Systems).
Immunohistochemistry and photography
Female mice were mated with males and either depleted for MDSC or control Ab-treated on gestation d E0.5 and E4.5. Mice were sacrificed on d E7.5, and their uteri were removed. Uteri from nonpregnant mice were also harvested. The uteri were photographed and then cryopreserved in OCT by freezing in a slurry of dry ice plus 2-methylbutane. Cryopreserved uteri were sectioned, fixed in cold acetone, dried, and stained with H&E or hematoxylin, and/or processed for immunohistochemistry. For immunohistochemistry, sections were blocked for endogenous peroxidase by pretreatment with hydrogen peroxide, stained overnight with primary Ab (5 mg/ml RB6-8C5 or CD3; BioLegend), then stained with secondary Ab, followed by streptavidin-HRP. Stained sections were developed with 3,39diaminobenzidine, counterstained with hematoxylin, dehydrated in graded alcohol, cleared in xylene, and then cover-slipped. Sections analyzed for MDSC and CD3 were photographed using an Olympus (Tokyo, Japan) BX-41 or Zeiss AxioImager Z.1 microscope (Carl Zeiss Microscopy, Thornwood, NY, USA), respectively. Unstained whole uteri were photographed using a Nikon D50 camera attached to a Nikon (Minato, Tokyo, Japan) PB-4 Bellows equipped with a 55-mm Micro-NIKKOR lens.
G-CSF or tumor induction of MDSCs
Mice were s.c. injected with PBS or 0-1000 mg/kg G-CSF for 3-4 consecutive d and bled 1 d after the last G-CSF injection. G-CSF was provided by Nora Therapeutics (NT-100). Mice were injected with 4T1 mammary carcinoma cells, as previously described [43] and bled on d 42-48 postinjection. Greater than 90% of blood leukocytes were CD11b + Gr1 + cells.
T cell sorting, labeling, and adoptive transfer of transgenic T cells 
1-MT
1-MT (Sigma-Aldrich, St. Louis, MO, USA) was dissolved in a minimum volume of 0.05N NaOH, and the final volume was adjusted with water to 2 mg/ml (pH 6.5-7.4). Two envelopes of Equal sweetener (1 g/envelope; Merisant Company, South Bend, IN, USA) were added per liter. 1-MT solution was filter-sterilized (0.45 m filter; EMD Millipore, Billerica, MA, USA), stored in the dark at 4°C, and used within 1 mo. Mice were administered 1-MT ad libitum using autoclaved, light-impermeable water bottles. Fresh 1-MT was provided weekly throughout gestation.
Statistical analyses
Data were analyzed using Student's unpaired 2-tailed t test (Microsoft Excel 2013; Microsoft, Redmond, WA, USA), ANOVA, or Fisher's 2-sided exact test. P , 0.05 was considered significant. 
Gr1
+ cells) and were cocultured with peptideactivated transgenic T cells at a ratio of 1:1 MDSC:T cells. Data are the means of 4 replicates from 1 of 2 independent experiments. Data were assessed for statistical significance with the Student's t test. **P , 0.01. Error bars represent SD.
RESULTS
Immune suppressive granulocytic MDSC (PMN-MDSC) increase in pregnancy
To determine whether MDSC levels in the blood increase with mating, female BALB/c (H-2 d ) mice were bled, and 7 d later were caged overnight or in the morning with allogeneic C57BL/ 6 (H-2 b ) males. Females that had mated were identified the following morning or afternoon by a vaginal mucous plug indicative of copulation. Separate groups of plugged females were subsequently bled on gestation d E4.5, E8.5, E12.5, E14.5, or E15.5 (Fig. 1A) . Using the most recently defined characteristics of MDSC [44] (Fig. 1B) . Similar to tumor-induced MDSCs, pregnancyinduced MDSCs inhibited both CD4 + and CD8 + T cell proliferation and activation as measured by tritiated thymidine uptake and IL-2 production. In contrast, control non-MDSC blood cells from pregnant mice were not suppressive. These results demonstrate that, as in pregnant women [12] , MDSCs accumulate in the blood of mice during pregnancy.
MDSCs are essential for implantation and subsequent pregnancy
If MDSCs contribute to maternal-fetal tolerance, then their depletion will reduce successful pregnancy and/or the number of live pups per mother. To test that possibility, BALB/c females were mated with C57BL/6 males, and plugged females were either MDSC (anti-Gr1) or control (irrelevant) Ab-depleted at varying times during gestation (Fig. 2) . Parallel studies demonstrated that administration of anti-Gr1 mAbs eliminated Gr1 1 ). Forty-six to 50% of control-treated, plugged mice delivered live pups, in accordance with The Jackson Laboratory-published birth rate for plugged BALB/c females [45] . In contrast, plugged females depleted for MDSC throughout gestation had 0% live births. MDSC depletion up to ;d E7 prevented successful pregnancy, whereas MDSC depletion on d E8.5 gave the same rate of successful pregnancy as the control treatment had.
Concepti were macroscopically visible in the uteri of control Ab-treated females and were absent in the uteri of MDSCdepleted females on d E7.5 (Fig. 3A) . H&E and immunohistochemistry staining of d E7.5 uteri (Fig. 3B) showed nests of Gr1 To determine whether MDSCs affect the influx of T cells into allogeneic embryos, uteri of irrelevant Ab-depleted and MDSC-depleted d E7.5 mice were also stained for CD3 + cells and analyzed by immunohistochemistry (Fig. 3C) . Uteri of control Ab-treated mice contained very few CD3 + cells. MDSCdepleted females contained approximately 29 times more CD3 + cells, consistent with the concept that MDSCs promote allogeneic pregnancy by limiting the number of T cells accessing the uterus.
To determine whether MDSCs are also involved in syngeneic pregnancy, BALB/c females plugged by BALB/c males were depleted for MDSC or treated with a control Ab on d E0.5, E4.5, and E8.5. Similar to allogeneic matings, MDSC depletion, but not control depletion, eliminated successful pregnancy (Supplemental Fig. 1B) .
Induction of MDSC in mice impaired for maternal-fetal tolerance restores successful pregnancy by inhibiting T cell activation
Seminal experiments by Munn et al. [11] demonstrated that retention of allogeneic embryos required the enzyme IDO because IDO catabolizes tryptophan and prevents T cell activation and proliferation. Munn et al. [11] used the IDO inhibitor 1-MT to demonstrate that inactivation of IDO caused fetal loss. IDO is also an inducer of MDSC [46] , and the IDO inhibitor 1-MT decreases the level of MDSCs in mice with elevated levels of circulating MDSCs (Supplemental Fig. 2 ). Because 1-MT restores T cell activation in pregnant mice, we reasoned that if MDSCs facilitate maternal-fetal tolerance, then mice treated with 1-MT could regain successful pregnancy if MDSC levels were enhanced. Because our MDSC depletion studies indicated that MDSC must be maintained in vivo through d ;E7 (Fig. 3) , we needed a reconstitution strategy that restored the in vivo production of MDSCs, rather than adoptive transfer of MDSCs, which would only produce transient elevation of the cells. G-CSF induces MDSCs in humans [47] and in mice [29, 38] , so we injected BALB/c and C57BL/6 females with various doses of G-CSF, and 7 d later measured the level of MDSCs in the blood (Fig. 4A) . Doses of G-CSF as low as 250 mg/kg raised the level of 
CD11b
+ cells were MDSCs, we tested blood and splenic Gr1 +
+ cells from G-CSF-treated mice for their ability to suppress the activation of Ag-specific CD4 + and CD8 + T cells, using T cell proliferation, IFN-g production, and IL-2 production as readouts (Fig. 4B) . G-CSF-induced Gr1 To determine whether induction of MDSCs restored successful pregnancy to mice impaired for maternal-fetal tolerance, plugged BALB/c females carrying allogeneic fetuses were continually treated with 1-MT 6 G-CSF starting on d E0.5 (Fig. 5) . Mice maintained on 1-MT and not receiving G-CSF had 0% successful pregnancies, whereas mice maintained on 1-MT and receiving G-CSF had successful pregnancies comparable to that of untreated mice. To ascertain that the effect of G-CSF was due to induction of MDSCs, plugged females were maintained on 1-MT plus G-CSF and depleted for MDSCs. These mice had no offspring. To determine whether MDSCs promote pregnancy by acting on T cells, MDSC-depleted mice were simultaneously Ab-depleted for MDSCs plus CD4 + and CD8 + T cells or MDSCs plus CD8 + T cells (Fig. 5) . Treatment with Abs to CD4 + and CD8 + T cells reduced the levels of CD4 + and CD8 + T cells to ,0.5% and ,3% of circulating leukocytes, respectively (Supplemental Fig. 3A) , and restored successful pregnancy to MDSC-depleted, plugged mice.
Concomitant depletion of MDSCs and CD8
+ and CD4 + T cells had the same effect as depletion of MDSCs and CD8 + T cells.
Levels of CD8
+ NK cells and CD8 + DCs were very low before depletion and were not significantly affected by T cell depletion (Supplemental Fig. 3B ). Therefore, MDSCs are essential for successful pregnancy and promote their effect by acting on T cells.
Pregnancy-induced MDSCs down-regulate L-selectin on circulating, naïve T cells and prevent T cell activation
Cancer-induced MDSCs directly interact with T cells to prevent T cell activation and also indirectly prevent T cell activation by inhibiting trafficking of naïve T cells to lymph nodes by downregulating L-selectin (CD62L) [26] . L-selectin is essential for activation of naïve T cells because it tethers T cells to high endothelial venules so they can extravasate from the circulatory system and enter lymph nodes where they are activated. Cancerinduced MDSCs reduce L-selectin in a contact-dependent process in which their plasma membrane ADAM-17 cleaves the extracellular domain of T cell-expressed L-selectin [26] . In contrast to human decidual tissue [48] , few T cells are present in the endometrium or uterus of pregnant mice before and during implantation [33] . This lack of T cells led us to hypothesize that pregnancy-induced MDSCs may down-regulate L-selectin on circulating, naïve T cells, thus preventing their entry into lymph nodes and reducing the number of activated T cells trafficking into the uterus. To test this hypothesis, we assessed the level of L-selectin on circulating CD3 + T cells from not-plugged, not-pregnant mice; pregnant mice; and plugged, MDSC-depleted mice. L-selectin was down-regulated on circulating, naïve T cells of pregnant mice but not on T cells of not-plugged, not-pregnant mice or plugged, MDSC-depleted mice (Fig.  6A) . Levels of MDSC in the blood were assessed in the same mice, and the down-regulation of L-selectin was inversely proportional to the quantity of circulating MDSCs. L-selectin down-regulation is mediated by MDSCs because depletion of MDSC from plugged mice restored L-selectin expression on naïve T cells.
Because G-CSF was used in Fig. 5 to restore MDSCs in 1-MT-treated mice, it was necessary to confirm that G-CSFinduced MDSCs and pregnancy-induced MDSCs had similar effects on L-selectin and T cell activation. Therefore, notpregnant, not-plugged, BALB/c, female mice were either untreated or treated with G-CSF, and depleted or not depleted for MDSCs. Their circulating PBMCs were subsequently analyzed for MDSCs, and their CD3 + T cells were analyzed for L-selectin expression (Fig. 6B) . Circulating T cells from G-CSF-treated mice had lower levels of L-selection as compared with T cells from untreated mice. MDSC depletion restored L-selectin levels, demonstrating that the decrease in L-selectin was mediated by MDSCs. Therefore, G-CSF and pregnancyinduced MDSCs similarly down-regulate L-selectin on circulating, naïve T cells.
To determine whether the down-regulation of L-selectin mediated by pregnancy-induced MDSCs reduced T cell activation, blood cells were harvested from not-plugged, not-pregnant; pregnant (E15.5); and plugged, MDSC-depleted mice (E16.5), and were analyzed by flow cytometry for T cell activation markers CXCR3, CD44, and CCR7 (Fig. 7A) . Significantly more CD3 + T cells were activated in plugged, MDSC-depleted mice as compared with pregnant mice, indicating that MDSCs in pregnant mice prevent T cell activation. These data indicate that pregnancy-induced MDSCs prevent T cell activation in vivo and are consistent with the concept that MDSC-mediated downregulation of L-selectin prevents T cells from entering lymph nodes and becoming activated.
To confirm that G-CSF-induced MDSCs and pregnancyinduced MDSCs have the same effect on in vivo T cell activation, female C57BL/6 CD45.1 mice were given G-CSF for 4 d, followed by adoptive transfer of CD45.2 OT1 transgenic T cells. Cognate peptide (SIINFEKL) was given the day after adoptive transfer, and the mice were sacrificed 2 d later, and their spleens, blood, and lymph nodes were analyzed for MDSCs and for activated OT-1 T cells (Fig. 7B) . Similar to pregnant mice, the G-CSF-treated mice contained fewer activated OT1 cells, as assessed by reduced expression of the T cell activation marker CXCR3. Collectively, these studies demonstrate that MDSCs induced by G-CSF have the same functions as pregnancy-induced MDSCs with respect to induction of L-selectin and inhibition of T cell activation in vivo and confirm the use of G-CSF as a drug to induce MDSCs in 1-MT-treated mice.
DISCUSSION
Multiple myeloid cell populations, including cells with the phenotype of MDSCs, have been identified in the uteri of early to midterm pregnant mice [33] , and functionally immune suppressive MDSCs have been identified in late-term pregnant mice [49] . Cells with the phenotype and function of MDSCs have also been identified in human placenta, and their presence positively correlates with successful pregnancy and inversely with spontaneous abortion in women [12, 32, 34] . The depletion and reconstitution studies presented here demonstrate that the accumulation of Gr1 + CD11b + cells not only correlates with successful pregnancy but is required for successful pregnancy and that the critical time for their function in mice is before and during implantation of the embryo. Furthermore, these studies also demonstrate that Gr1 + CD11b + cells are required for successful pregnancy because they impair T cell activation.
In addition to preventing T cell activation, MDSCs may also facilitate successful pregnancy through nonimmune Figure 5 . Induction of MDSCs in mice impaired for maternal-fetal tolerance restores successful pregnancy by inhibiting T cell activation. Female BALB/c mice were caged overnight or in the morning with male C57BL/6 mice. The following morning or afternoon, respectively (d E0.5), plugged females were placed on water 6 2 mg/ml 1-MT 6 G-CSF (1000 mg/kg/d) 6 MDSCs or control Ab depletion 6 CD4 plus CD8 T cell depletion, or untreated, and followed for delivery of live offspring. Mice depleted for CD4 + or CD4 + and CD8 + T cells were started on T cell-depleting Abs before mating. Data are pooled from 2-5 independent experiments in which multiple females were mated and plugged over the course of several days. Numbers of mice/group are indicated in the figure. Statistical analysis was with Fisher's exact test. 1, According to the Jackson Laboratory, the normal pregnancy rate for BALB/c mice is 31-44% of plugged females (http://jaxmice.jax. org/jaxnotes/archive/501d.html; §, Groups that are not significantly different from each other and are significantly different from groups without § (P , 0.004). Groups without § are not significantly different from each other.
mechanisms. Neovascularization and trophoblast invasiveness into the uterine wall are essential for decidualization and establishment of the placenta. MDSCs secrete the key proangiogenesis inducer VEGF as well as matrix metalloproteinase-9 and Bv8, which are essential for trophoblast invasiveness in mice [29, 31] . These latter activities are essential before and during implantation, suggesting that MDSCs may also have a key role in these nonimmune functions required for successful pregnancy.
MDSCs may mediate their effects both in the uterus and in the periphery. Their localization in the uterus is not surprising because decidual stromal cells in humans produce high levels of CCL2 [36] , a chemoattractant for MDSCs [50] . In addition, the proinflammatory mediators and regulatory molecules that we detect in the uterus (TNF-a, IL-6, IL-1b, and cyclooxygenase 2/PTGS2) drive the accumulation of MDSCs in mice [18, 19, 51, 52] . The presence of MDSCs in the uteri of pregnant mice suggests that the few T cells that gain access to the embryo may be suppressed. However, whether MDSCs in the uterus are functioning as suppressor cells and/or are promoting implantation through their production of degradative enzymes is unclear. MDSCs also appear to promote maternal-fetal tolerance in the periphery through their ability to reduce L-selectin levels on naïve T cells, thereby inhibiting T cell entry into lymph nodes and T cell activation.
Previous studies have demonstrated a role for T regs [7] [8] [9] , IDO [11] , and immune-suppressive DCs [10] , among other factors, in maternal-fetal tolerance. MDSCs can induce T regs [28, 53] and produce IDO [54] , and elevated production of MDSCs impairs the differentiation of DCs [52] . Therefore, it is theoretically possible that MDSCs orchestrate some, or perhaps many, of the mechanisms that promote maternal-fetal tolerance. This latter possibility, however, is unlikely for several reasons. For example, multiple myeloid cell populations, including DCs, produce IDO [55] ; T regs are also induced by factors independent of MDSCs [56] , and immune-suppressive ("regulatory") DCs are induced by multiple tumor-derived factors [57] . Therefore, MDSCs are necessary, however, it is unlikely that they, alone, are sufficient for generating maternal-fetal tolerance.
Allogeneic pregnancies most likely require maternal-fetal tolerance because of fetal expression of MHC alloantigens. However, syngeneic pregnancies, a circumstance virtually unique to inbred strains of experimental animals, may also require immune suppression because of expression of immunogenic embryonic/fetal Ags. The potential for embryos to express immunogenic fetal Ags is supported by studies showing that mouse blastocysts activate T cells of syngeneic female mice [58] . Other studies showed that the H-Y (male) Ag is immunogenic in pregnant syngeneic females because H-Y-expressing male fetuses elicit proliferation of maternal splenocytes [59] . The latter studies also showed that depletion of T regs in females carrying syngeneic H-Y-expressing fetuses resulted in reduced rates of male offspring, suggesting that maternal-fetal tolerance to H-Y requires T regs . In contrast, the seminal studies of Munn et al. [11] did not observe either a decrease in the frequency of pregnancy or in the number of live births per litter in syngeneic matings in which the mothers were treated with 1-MT. Those authors also did not observe an effect of 1-MT on pregnancy in T celldeficient RAG 2/2 mice. Thus, these earlier studies, which focused on T cells, leave unsettled whether T reg -mediated tolerance is required in the syngeneic setting. Our results showing that MDSC depletion reduces the rate of successful syngeneic pregnancy, combined with the studies of others showing that MDSCs accumulate in pregnant female mice carrying fully syngeneic offspring [33, 59] , suggest that MDSC-mediated tolerance is required for successful syngeneic pregnancy. Whether the requirement for MDSCs is due to Neutrophils also coexpress Gr1 and CD11b. and other granulocyte populations express Gr1. However, those other cell populations typically do not have suppressive functions. Therefore, it is possible that the cells we have identified in the uterus and blood of pregnant mice may include classic granulocytes and neutrophils in addition to MDSCs. G-CSF mobilizes other blood cells in addition to MDSCs. To control for these potential non-MDSC effects of G-CSF and Gr1-mediated MDSC-depletion, we treated mice with G-CSF followed by depletion with anti-Gr1 Abs. Although both of these treatments may have other effects in addition to their impact on MDSCs, it is highly unlikely that their non-MDSC effects overlapped. Thus, by showing that Gr1 depletion negates the effects of G-CSF treatment, it is likely that the observed effects are due to MDSCs.
Depletion studies are clearly not feasible in pregnant women; however, there is considerable observational evidence in women indicating that MDSCs are associated with successful pregnancies. For example, immune-suppressive cells with the characteristics of MDSCs accumulate in women during successful pregnancy [12] , and pregnant women with reduced levels of suppressive monocytes in their blood and endometrium have higher incidences of early miscarriage [34] . Arginase, a major effector molecule of MDSCs [23] , is elevated in the placenta of pregnant women and mediates T cell hyporesponsiveness [35] . Inadequate Ag presentation and T cell activation by DCs are associated with human reproductive failure [10] , and MDSCs impair human DC function by inhibiting DC maturation and by blocking DC activation of T cells [60] .
As our data with mice demonstrate, provision of G-CSF promotes successful pregnancy by inducing MDSCs. Administration of G-CSF may also promote human pregnancy because G-CSF treatment of a small group of women with a history of recurrent miscarriages of unexplained etiology increased their rates of successful pregnancy [39, 40] . Therefore, administration of G-CSF may facilitate pregnancy by inducing MDSCs, and such therapy may benefit women who are at high risk of spontaneous abortion or miscarriage because of insufficient maternal-fetal tolerance. 
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